By proceeding, you agree to our Terms of Use and Privacy Policy.
Biopharmaceutical industry professional providing expertise and strategy to organizations and executive teams to build and advance their portfolio of novel therapies focused on acquired and rare metabolic diseases.
Talks About #drugdiscovery #clinicaldevelopment #businessstrategy
Preferred Locations #NorthAmerica
Welcome to the 6th Obesity & NASH Drug Development Summit There has been a rise and fall of investment in NASH in the wake of highly demanding biopsy endpoints and late-stage clinical setbacks.
